BREAKING
NEW
21:30
World Cup 2026: Spain 2:1 Belgium — Match Report
20:45
Apollo's EasyJet Bid Puts U.S. Private Equity in Pilot Seat
20:25
Hormuz Oil Shock Tightens Grip on U.S. Fuel Price Outlook
20:05
Maine Senate Race Shifts as Democrats Jostle for Ballot Spot
09:45
SK Hynix's Nasdaq Debut Tests U.S. Appetite for Chip Giants
09:25
ICE Shooting Protests Put White House on Defense in Texas
09:05
Protein Timing in Heat Becomes Key Focus for U.S. Dietitians
22:30
World Cup 2026: France 2:0 Morocco — Match Report
20:45
AI Salaries Fuel U.S. EV Insurance Gap, Analysts Warn
20:25
AI Wealth Boom Pushes San Francisco Median Home to $1.7M
US Politics
Economy
Finance
Sports
Entertainment
Society
Health
Auto
Digital
World
World Cup 2026
Tools
CITIES
New York
Los Angeles
Chicago
Houston
Miami
Washington
San Francisco
Seattle
News
Zen
News
SECTIONS
US Politics
99 Articles
Senate & Congress
Democrats
Republicans
White House
World
144 Articles
Ukraine War
Middle East
NATO
China
UN & Diplomacy
Economy
45 Articles
Markets
Trade
Housing
Inflation
Tech
70 Articles
AI
Big Tech
Cybersecurity
Social Media
Electric Vehicles
Society
87 Articles
Immigration
Education
Crime
Environment
Cost of Living
Health
26 Articles
NHS
Mental Health
Vaccines
Nutrition
Sports
133 Articles
Premier League
Champions League
F1
Cricket
Tennis
Climate
96 Articles
Net Zero
Renewable Energy
Extreme Weather
⭐ Daily Horoscope
Contact the Newsroom
Results for “Diabetes”
12 results
Search
All
12
Health
10
Economy
2
Health
24 Jun 2026
Type 1
Diabetes
Drug Delay Puts U.S. Insurers on Defense
European immunotherapy approvals for Type 1
diabetes
are prompting U.S. insurers to reassess coverage of preventative treatments …
Health
09 Jun 2026
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Ozempic and Wegovy-related muscle loss is spurring a major drug development race, with analysts predicting a $50+ billion market …
Health
12 Jun 2026
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Novo Nordisk's Wegovy oral tablet formulation of semaglutide intensifies competition in the U.S. GLP-1 weight-loss drug market, s…
Health
21 Jun 2026
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Novo Nordisk's Wegovy pill formulation submission to the FDA is intensifying competition in the obesity drug market, prompting sc…
Health
24 Jun 2026
Workplace Walk Breaks Gain Traction in U.S. Corporate Policy
U.S. companies are increasingly implementing workplace walk breaks to combat rising inactivity among American adults, addressing …
Health
25 Jun 2026
Obesity Surge in Young Adults Strains U.S. Medicaid Budgets
Cost-of-living pressures and ultra-processed foods drive caseload spike
Economy
06 Jul 2026
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Oral GLP-1 drugs enter market as coverage battles intensify across America
Health
26 Jun 2026
Cardiac Arrest Risk in Heat Puts U.S. Workplace Rules in Focus
OSHA faces pressure to expand outdoor heat standards beyond elderly workers
Health
05 Jul 2026
Obesity Crisis Hits Hardest Among U.S. Young Adults
New data challenges long-held assumptions about age and weight gain risk
Economy
08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
Health
Yesterday
Measles Surge Abroad Puts U.S. Vaccination Policy Under Scrutiny
Bangladesh crisis renews CDC debate over domestic immunization gaps
Health
15 hrs ago
Protein Timing in Heat Becomes Key Focus for U.S. Dietitians
Extreme summer temps push American nutrition experts to rethink meal planning advice
Topics:
NHS Policy
Ukraine War
NHS
Net Zero
Starmer
Zero
League
Artificial Intelligence
Ukraine
Senate
Russia
Champions
Champions League
Mental
Health
Renewable Energy
Final
Bill
Grid
Block
Target
Energy
Security
Council
Home
Search
Live
Sections
More